연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Veterinary Pathobiology,
Bond Life Sciences Center,
Department of Veterinary Pathobiology, Bond Life Sciences Center
Monir Shababi has not added Biography.
If you are Monir Shababi and would like to personalize this page please email our Author Liaison for assistance.
A cytosolic domain of the yeast Zrt1 zinc transporter is required for its post-translational inactivation in response to zinc and cadmium.
The Journal of biological chemistry Oct, 2003 | Pubmed ID: 12893829
The ribosomal shunt translation strategy of cauliflower mosaic virus has evolved from ancient long terminal repeats.
Journal of virology Apr, 2006 | Pubmed ID: 16571798
Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
Molecular therapy : the journal of the American Society of Gene Therapy Jul, 2006 | Pubmed ID: 16580882
Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
Molecular therapy : the journal of the American Society of Gene Therapy Aug, 2007 | Pubmed ID: 17551501
Development of a single vector system that enhances trans-splicing of SMN2 transcripts.
PloS one , 2008 | Pubmed ID: 18941511
Spinal muscular atrophy: mechanisms and therapeutic strategies.
Human molecular genetics Apr, 2010 | Pubmed ID: 20392710
Cardiac defects contribute to the pathology of spinal muscular atrophy models.
Human molecular genetics Oct, 2010 | Pubmed ID: 20696672
Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy.
Human gene therapy Feb, 2011 | Pubmed ID: 20804424
Therapeutics that directly increase SMN expression to treat spinal muscular atrophy.
Drug news & perspectives Oct, 2010 | Pubmed ID: 21031163
Optimization of SMN Trans-Splicing Through the Analysis of SMN Introns.
Journal of molecular neuroscience : MN Aug, 2011 | Pubmed ID: 21826391
Decreasing Disease Severity in Symptomatic, Smn(-/-);SMN2(+/+), Spinal Muscular Atrophy Mice Following scAAV9-SMN Delivery.
Human gene therapy Jan, 2012 | Pubmed ID: 22029744
Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy.
Biochemical and biophysical research communications Jan, 2012 | Pubmed ID: 22172949
Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.
Journal of molecular and cellular cardiology Jan, 2012 | Pubmed ID: 22285962
University of Missouri
Jacqueline J. Glascock1,
Erkan Y. Osman1,
Tristan H. Coady2,
Ferrill F. Rose1,
Monir Shababi3,
Christian L. Lorson3
1Department of Molecular Microbiology and Immunology, Bond Life Sciences Center, University of Missouri,
2Department of Biological Sciences, Columbia University ,
3Department of Veterinary Pathobiology, Bond Life Sciences Center, University of Missouri
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유